Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Pancreatic Ductal 1 Advanced Solid Tumors 1 Adenocarcinoma 1

Interventions

Gemcitabine 27 Fluorouracil 25 Oxaliplatin 21 Cisplatin 19 Leucovorin 17 Bevacizumab 15 130-nm albumin-bound paclitaxel 13 Docetaxel 12 Capecitabine 12 Albumin-Bound Paclitaxel 12 Paclitaxel 11 Irinotecan 10 Carboplatin 9 pembrolizumab 7 Radiotherapy 6 Pemetrexed 6 Nivolumab 6 Erlotinib Hydrochloride 6 Cyclophosphamide 6 Trastuzumab 5 Ramucirumab 5 Ipilimumab 4 Everolimus 4 Crizotinib 4 Cetuximab 4 vandetanib 3 trastuzumab deruxtecan 3 sargramostim 3 folfirinox 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenocarcinoma × Atu027 × Clear all

NCT01808638 2016-03-11

Atu027-I-02

Silence Therapeutics GmbH

Phase 1/2 Completed

Gastrointestinal

Adenocarcinoma, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡